RATIONALE AND OBJECTIVE: Protein kinase C (PKC) modulation of ionotropic receptors is a common mechanism for regulation of channel function. The effects of PKC and phosphatase activation on native gamma-aminobutyric acid (GABA(A)) receptors in adult brain are unknown. Previous studies of recombinant GABA(A) receptors have provided evidence that PKC activation inhibits receptor function, whereas other studies suggest that PKC either increases or does not alter GABA(A) receptor function. The present study explored (a) the effects of PKC and phosphatase activity on GABA-mediated (36)Cl(-) uptake in cerebral cortical synaptoneurosomes and (b) the effect of PKC activity on muscimol-induced loss of righting reflex (LORR) in adult rats. METHODS: GABA(A) receptor function in vitro was measured by muscimol-induced (36)Cl(-) uptake into cerebral cortical synaptoneurosomes. The in vivo effect of PKC on GABA(A)-mediated function was measured by intracerebroventricular (i.c.v.) injection of 4-beta-phorbol-12,13-dibutyrate (PDBu) or calphostin C followed by determination of muscimol-induced LORR. RESULTS: Adenosine triphosphate (ATP) and PDBu produced a concentration-dependent and specific reduction in muscimol-stimulated (36)Cl(-) uptake that was blocked by the PKC inhibitor calphostin C. Both adenosine diphosphate and 4alphaPDBu were ineffective. Phosphatase inhibition produced similar inhibition of muscimol responses. Furthermore, i.c.v. administration of PDBu and calphostin C produced opposing effects on both the onset and the duration of muscimol-induced LORR in rats. CONCLUSIONS: The present study provides evidence that PKC activation reduces GABA(A) receptor function in native receptors both in vitro and in vivo. Phosphatase inhibitors decrease muscimol-mediated Cl(-) uptake in GABA(A) receptors demonstrating coordinated regulation of native receptors by PKC and phosphatases.
RATIONALE AND OBJECTIVE: Protein kinase C (PKC) modulation of ionotropic receptors is a common mechanism for regulation of channel function. The effects of PKC and phosphatase activation on native gamma-aminobutyric acid (GABA(A)) receptors in adult brain are unknown. Previous studies of recombinant GABA(A) receptors have provided evidence that PKC activation inhibits receptor function, whereas other studies suggest that PKC either increases or does not alter GABA(A) receptor function. The present study explored (a) the effects of PKC and phosphatase activity on GABA-mediated (36)Cl(-) uptake in cerebral cortical synaptoneurosomes and (b) the effect of PKC activity on muscimol-induced loss of righting reflex (LORR) in adult rats. METHODS:GABA(A) receptor function in vitro was measured by muscimol-induced (36)Cl(-) uptake into cerebral cortical synaptoneurosomes. The in vivo effect of PKC on GABA(A)-mediated function was measured by intracerebroventricular (i.c.v.) injection of 4-beta-phorbol-12,13-dibutyrate (PDBu) or calphostin C followed by determination of muscimol-induced LORR. RESULTS:Adenosine triphosphate (ATP) and PDBu produced a concentration-dependent and specific reduction in muscimol-stimulated (36)Cl(-) uptake that was blocked by the PKC inhibitor calphostin C. Both adenosine diphosphate and 4alphaPDBu were ineffective. Phosphatase inhibition produced similar inhibition of muscimol responses. Furthermore, i.c.v. administration of PDBu and calphostin C produced opposing effects on both the onset and the duration of muscimol-induced LORR in rats. CONCLUSIONS: The present study provides evidence that PKC activation reduces GABA(A) receptor function in native receptors both in vitro and in vivo. Phosphatase inhibitors decrease muscimol-mediated Cl(-) uptake in GABA(A) receptors demonstrating coordinated regulation of native receptors by PKC and phosphatases.
Authors: Clyde W Hodge; Jacob Raber; Thomas McMahon; Helen Walter; Ana Maria Sanchez-Perez; M Foster Olive; Kristin Mehmert; A Leslie Morrow; Robert O Messing Journal: J Clin Invest Date: 2002-10 Impact factor: 14.808
Authors: Rebecca J Howard; Samuel Murail; Kathryn E Ondricek; Pierre-Jean Corringer; Erik Lindahl; James R Trudell; R Adron Harris Journal: Proc Natl Acad Sci U S A Date: 2011-07-05 Impact factor: 11.205
Authors: Jessica L Santerre; Eduardo D Gigante; Justine D Landin; David F Werner Journal: Psychopharmacology (Berl) Date: 2013-09-20 Impact factor: 4.530
Authors: Candice E Van Skike; Paolo Botta; Vivien S Chin; Sayaka Tokunaga; Janelle M McDaniel; Jacob Venard; Jaime L Diaz-Granados; C Fernando Valenzuela; Douglas B Matthews Journal: Alcohol Clin Exp Res Date: 2010-09-22 Impact factor: 3.455
Authors: David F Werner; Sandeep Kumar; Hugh E Criswell; Asha Suryanarayanan; J Alex Fetzer; Chris E Comerford; A Leslie Morrow Journal: J Neurochem Date: 2011-01-19 Impact factor: 5.372
Authors: Sandeep Kumar; Patrizia Porcu; David F Werner; Douglas B Matthews; Jaime L Diaz-Granados; Rebecca S Helfand; A Leslie Morrow Journal: Psychopharmacology (Berl) Date: 2009-05-20 Impact factor: 4.530
Authors: Stephen P Kelley; Jamie K Alan; Todd K O'Buckley; Steven Mennerick; Kathiresan Krishnan; Douglas F Covey; A Leslie Morrow Journal: Eur J Pharmacol Date: 2007-06-29 Impact factor: 4.432